Guerbet Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GUERBET, and what generic alternatives to GUERBET drugs are available?
GUERBET has five approved drugs.
There are three US patents protecting GUERBET drugs.
There are seventy-three patent family members on GUERBET drugs in twenty-six countries and one supplementary protection certificate in one country.
Summary for Guerbet
| International Patents: | 73 |
| US Patents: | 3 |
| Tradenames: | 6 |
| Ingredients: | 5 |
| NDAs: | 5 |
| Drug Master File Entries: | 1 |
Drugs and US Patents for Guerbet
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Guerbet | ELUCIREM | gadopiclenol | SOLUTION;INTRAVENOUS | 216986-006 | Sep 21, 2022 | RX | Yes | Yes | 10,973,934 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Guerbet | ELUCIREM | gadopiclenol | SOLUTION;INTRAVENOUS | 216986-005 | Sep 21, 2022 | RX | Yes | Yes | 8,114,863 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Guerbet | ELUCIREM | gadopiclenol | SOLUTION;INTRAVENOUS | 216986-001 | Sep 21, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Guerbet | DOTAREM | gadoterate meglumine | SOLUTION;INTRAVENOUS | 204781-003 | Mar 20, 2013 | AP | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Guerbet
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Guerbet | HEXABRIX | ioxaglate meglumine; ioxaglate sodium | INJECTABLE;INJECTION | 018905-002 | Jul 26, 1985 | 4,065,554 | ⤷ Try a Trial |
| Guerbet | HEXABRIX | ioxaglate meglumine; ioxaglate sodium | INJECTABLE;INJECTION | 018905-002 | Jul 26, 1985 | 4,094,966 | ⤷ Try a Trial |
| Guerbet | HEXABRIX | ioxaglate meglumine; ioxaglate sodium | INJECTABLE;INJECTION | 018905-002 | Jul 26, 1985 | 4,014,986 | ⤷ Try a Trial |
| Guerbet | OXILAN-350 | ioxilan | INJECTABLE;INJECTION | 020316-002 | Dec 21, 1995 | 4,954,348 | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Guerbet Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2022009463 | ⤷ Try a Trial |
| South Korea | 101440761 | ⤷ Try a Trial |
| European Patent Office | 1931673 | ⤷ Try a Trial |
| Chile | 2021001868 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Guerbet Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1931673 | 301259 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: GADOPICLENOL; REGISTRATION NO/DATE: EU/1/23/1772 20231208 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
